VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 19 filers reported holding VERONA PHARMA PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,150,000 | -16.0% | 751,905 | 0.0% | 0.12% | -6.1% |
| Q1 2022 | $3,752,000 | -25.7% | 751,905 | 0.0% | 0.13% | -19.0% |
| Q4 2021 | $5,053,000 | +22.6% | 751,905 | 0.0% | 0.16% | +22.6% |
| Q3 2021 | $4,120,000 | -16.2% | 751,905 | 0.0% | 0.13% | -16.9% |
| Q2 2021 | $4,917,000 | -21.8% | 751,905 | 0.0% | 0.16% | -25.9% |
| Q1 2021 | $6,286,000 | +19.4% | 751,905 | 0.0% | 0.22% | +16.8% |
| Q4 2020 | $5,263,000 | +77.4% | 751,905 | +58.2% | 0.18% | +66.7% |
| Q3 2020 | $2,967,000 | +151.0% | 475,402 | +87.8% | 0.11% | +146.7% |
| Q2 2020 | $1,182,000 | +13.3% | 253,179 | 0.0% | 0.04% | -4.3% |
| Q1 2020 | $1,043,000 | -34.0% | 253,179 | -7.9% | 0.05% | -21.7% |
| Q4 2019 | $1,581,000 | +25.8% | 275,000 | 0.0% | 0.06% | +9.1% |
| Q3 2019 | $1,257,000 | -14.5% | 275,000 | 0.0% | 0.06% | -8.3% |
| Q2 2019 | $1,471,000 | -14.4% | 275,000 | 0.0% | 0.06% | -14.3% |
| Q1 2019 | $1,719,000 | -30.5% | 275,000 | 0.0% | 0.07% | -34.0% |
| Q4 2018 | $2,475,000 | -28.1% | 275,000 | 0.0% | 0.11% | -15.2% |
| Q3 2018 | $3,440,000 | -9.0% | 275,000 | 0.0% | 0.12% | -12.6% |
| Q2 2018 | $3,781,000 | -31.3% | 275,000 | 0.0% | 0.14% | -33.2% |
| Q1 2018 | $5,500,000 | +67.8% | 275,000 | 0.0% | 0.21% | +69.8% |
| Q4 2017 | $3,278,000 | -22.3% | 275,000 | 0.0% | 0.13% | -16.6% |
| Q3 2017 | $4,221,000 | +31.5% | 275,000 | 0.0% | 0.15% | +26.9% |
| Q2 2017 | $3,211,000 | – | 275,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |